IP 173 (Memantine Hydrochloride 5 mg)
Pill with imprint IP 173 is Orange, Rectangle and has been identified as Memantine hydrochloride 5 mg. It is supplied by Amneal Pharmaceuticals of New York, LLC.
Memantine is used in the treatment of alzheimer's disease; migraine; autism and belongs to the drug class miscellaneous central nervous system agents. There is no proven risk in humans during pregnancy. Memantine 5 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for IP 173
Memantine hydrochloride
- Imprint:
- IP 173
- Strength:
- 5 mg
- Color:
- Orange
- Shape:
- Rectangle
- Availability:
- Prescription only
- Drug Class:
- Miscellaneous central nervous system agents
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Amneal Pharmaceuticals of New York, LLC
- National Drug Code (NDC):
- 53746-0173
More about memantine
- Memantine Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 35 Reviews – Add your own review/rating
- Drug class: miscellaneous central nervous system agents
Consumer resources
- Memantine
- Memantine Tablets
- Memantine Extended-Release Capsules
- Memantine Solution
- Memantine (Advanced Reading)
Other brands: Namenda, Namenda XR
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
